Resources
Reference material on US market entry. Letters from our partners are published separately in The Cardiac Ledger.
All resources
Transparency in MedTech investor communications
Why realistic regulatory, clinical and reimbursement plans build more investor confidence than optimistic timelines.
Understanding FDA Breakthrough Device designation
What the designation does and does not do, and how to approach it as part of a wider regulatory strategy.
A MedTech executive’s guide to commercializing in the US
An overview of the decisions that shape US market entry, from product development and funding through go-to-market planning.

